Updated Nov 4, 2026FDA and CMS public dataIndependent · free · not health advice
GxRadar
Drugs/Glipizide 5 mg tablet
Diabetes

Glipizide 5 mg tablet

Public data on glipizide from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.

$0.0328
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-7%
change over five years
peak $0.0369 in 2022-02
21
approved generic applications (ANDAs) on record for Glipizide
12 with a product still marketed · first 1994
Not listed
in FDA's current shortage list
no matching FDA shortage entries

NADAC per unit, monthly

GLIPIZIDE 5 MG TABLET
Show as table
MonthNADAC per unit ($)
2013-110.03158
2014-020.03351
2014-050.03297
2014-080.03189
2014-110.03087
2015-020.03150
2015-050.02982
2015-080.02929
2015-110.02604
2016-020.02851
2016-050.02795
2016-080.02712
2016-110.02747
2017-020.02882
2017-050.02776
2017-080.02916
2017-110.02878
2018-020.02580
2018-050.02672
2018-080.02768
2018-110.02756
2019-020.02878
2019-050.02831
2019-080.03370
2019-110.03278
2020-020.03241
2020-050.03227
2020-080.03316
2020-110.03274
2021-020.03233
2021-050.03131
2021-080.03185
2021-110.03540
2022-020.03691
2022-050.03510
2022-080.03538
2022-110.03511
2023-020.03612
2023-050.03585
2023-080.03482
2023-110.03442
2024-020.03444
2024-050.02946
2024-080.03157
2024-110.02964
2025-020.03106
2025-050.03379
2025-080.03451
2025-110.03542
2026-020.03571
2026-050.03592
2026-080.03501
2026-110.03285

Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.

Recall records mentioning glipizide

openFDA enforcement records, by year reported.

20251
20211
20191
20181
20175
20161
20152
20142

14 records since 2012. A record is one product or lot, not one recall event. Combination products that contain glipizide are included.

What these numbers mean

NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.

Most recent recall records

Class IITerminated
Glipizide product
Reason category: Dissolution failure
FDA recall number D-0202-2025
Class IITerminated
Glipizide product
Reason category: Dissolution failure
FDA recall number D-0020-2022
Class IITerminated
Glipizide product
Reason category: Labeling or packaging error
FDA recall number D-1276-2019
Class IITerminated
Glipizide product
Reason category: cGMP deviations
FDA recall number D-0010-2019
Class IIITerminated
Glipizide product
Reason category: Failed specifications (other)
FDA recall number D-1058-2017

Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.

Articles that mention glipizide

4 GxRadar articles cite or discuss this drug.

PRICE INDEX · 2014 = 100
Price histories · Data story · 6 min

The generics that cost pharmacies more than they did in 2014

Most generics in GxRadar's 47-drug basket got cheaper. Seven cost pharmacies more than in January 2014, led by furosemide at 2.8 times its 2014 price. What federal cost and shortage data show, drug by drug.

Using medicines safely · Explainer · 6 min

Look-alike and sound-alike drug names, and how FDA tries to keep them apart

How FDA screens new drug names with its POCA software, why generic names can resemble each other, how tall man lettering works, and what recall records show about mix-ups.

Manufacturing quality · Explainer · 6 min

Dissolution testing, the lab check behind many tablet recalls

How a dissolution test measures whether a pill releases its drug, how USP and FDA set the pass mark, and what 414 recall records citing dissolution show about which products fail.

PRICE INDEX · 2014 = 100
Price histories · Data story · 6 min

The GxRadar generic price index

We priced a fixed basket of 43 common generics every month since January 2014. By October 2026 the index stood at 47.4, down about 53 percent. How it works, and where it can mislead.